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Meningococcal infections continue to pose a serious medical and public 
health problem, due in part to the emergence of sulfa-resistant organisms (re- 
viewed in reference 1). Since antibiotics no longer are regularly effective in 
eradicating meningococci from the nasopharynx of carriers (2), protection of a 
population from clinical infection may well necessitate acquired immunity. 
Opsonization of microorganisms is considered one of the major protective functions 
of antibodies in the host defense system. By this mechanism, homologous opsonins 
specifically promote phagocytosis of bacteria by combining with antiphagocytic 
surface antigens (3). Such antigens have been well defined for two pathogens, the 
Group A streptococcus (type M protein) and the pneumococcus (type-specific capsular 
polysaccharide) (4, 5). 
Previous studies have demonstrated that phagocytosis of meningococci by rabbit 
polymorphonuclear leukocytes occurs only in the presence of antisera from rabbits 
immunized with log-phase organisms, suggesting that these bacteria may also have 
surface antigens which exert an antiphagocytic effect (6). Gotschlich, Liu, and Arten- 
stein recently purified polysaccharides from meningococci of groups A and C (7), and 
detected hemagglntinating and bactericidal activity in sera of human volunteers 
immunized with 50 #g of these polysaccharides (8). 
This report describes the interaction in vitro between human granulocytes 
and rneningococci in the presence of sera from these immunized volunteers. In 
addition, the relationship between groups A and C polysaccharide and meningo- 
coccal opsonins in sera from naturally infected individuals was also studied. 
The findings indicate that meningococcal polysaccharides produce group- 
specific opsonins in man and that these polysaccharides are the major anti- 
phagocytic determinants for group A and group C meningococci. 
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United States Army Medical Research and Development Command. 
This work was presented in part at the 61st Annual Meeting of The American Society 
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Materials and Methods 
Prototype group A(A-1), B(B-I1), and C(C-11) meningococcal strains, group A and group 
C  polysaccharides, and sera from immunized volunteers were kindly supplied by Dr. M. S. 
Artenstein, Department of Bacterial Diseases, Walter Reed Army Research Institute, Wash- 
ington,  D.  C.,  and  Dr.  E.  C.  Gotschlich, The  Rockefeller  University, New  York.  Other 
meningococcal strains and human sera were generously provided  by Dr.  H.  Feldman,  Dr. 
D. Ivler, Dr. M. Schaeffer, and Dr. J. G. Hirsch. 
Leukocyte  suspensions were  prepared  from  blood  drawn  from  normal  volunteers  and 
mixed  with  an  equal  volume  of  physiologic saline containing 0.02%  heparin  (Connaught 
Medical Research Laboratories, Toronto,  Canada)  and  2%  Dextran 250  (Pharmacia Fine 
Chemicals, Uppsala, Sweden). Tubes with this mixture were slanted at 45  °  for  15  min  at 
room  temperature to allow for red ceil sedimentation. The leukocyte-rich plasma was  then 
collected and  the volume and granulocyte count determined. Leukocytes  were  sedimented 
at 200 g for 10 min, washed first in heparinlzed saline and then in saline alone, and resus- 
pended to the desired concentration in sterile Gey's balanced salt solution (Microbiological 
Associates, Inc., Bethesda, Md.) with 0.1% gelatin (Difco Laboratories, Inc., Detroit, Mich.). 
Broth cultures of meningococcal strains with less than five serial passages after primary 
isolation were stored in small portions at --65°C. Maintenance of daily cultures and the prepa- 
ration of bacterial suspensions for phagocytosis have been described previously  (6i. In the 
present studies,  2-21/~  hr-shaking broth cultures  were  used  for phagocytosis  experiments. 
Human sera were stored in small portions at --20°C and thawed immediately before each 
experiment. Immune sera frozen for more than 4 wk were inactivated at 56°C for 30 rain prior 
to each test and supplemented with 10% fresh normal serum. 
Preparation of phagocytosis tests and the enumeration of viable bacteria have been de- 
scribed previously (6). Two controls were included in the present experiments: ]First,  an im- 
mune serum control without leukocytes to rule out the bactericidal effect of serum alone, and 
second, a  fresh normal serum control with cells to rule out phagocytosis in the presence of 
normal serum. A phagocytosis test was considered positive when greater than 90% of orga- 
nisms were killed after 1 hr of incubation at 37°C. 
For absorption studies, log-phase organisms from 3-hr-shaking broth cultures were sedi- 
meuted at  12,800  g for  10 min. The supernate was removed and to the remaining 0.05 ml 
bacterial pellet was added 0.5 ml serum. The bacteria were resuspended gently and the bac- 
teria-serum mixture incubated at 4°C for 2 hr. After centrifugation the serum was removed 
and stored at  --20°C.  Serum was absorbed with purified polysaccharides by two methods. 
Alum-absorbed polysaccharide (100#g)  prepared by Dr.  Gotschlich (9)  was  incubated with 
serum (1 : 10 vol/vol) at 4°C for 2 hr. After centrifugation at 12,800 g for 10 min, the serum 
was decanted and stored as above. Most absorption experiments, however, were performed 
by directly adding group A  (lot A-V) and group C  (lot C-I)  polysaccharides to other com- 
ponents of the phagocytosis system. 1 Thus, in phagocytosis tubes were placed 0.6 ml leuko- 
cytes  (2  X  107 granulocytes/ml)  0.1  ml heat-inactivated  test serum,  0.1  ml fresh normal 
serum, 0.1 ml bacteria (1-2)<  107 organisms/ml), and  0.1 ml  purified polysaccharide (0.1- 
100 ~g/ml). 
Studies of the neutralization of opsonic activity in group A  and group C  polysaccharide 
antisera were conducted with the following haptens: mannose, mannosamine, N-acetyl man- 
nosamine, N-acetyl glucosamine, N-acetyl  galactosamine  (Sigma Chemical  Co.,  St.  Louis, 
Mo.),  N-acetyl  neuramlnic  acid  (Calbiochem,  Los  Angeles,  Calif.),  N-acetyl-4-O-acetyl 
neuraminic acid,  and N-acetyl-7-O, 8-O-diacetyl neuraminic acid.  The  latter  two free acyl- 
neuraminic acids were purified  from  horse and  bovine submaxillary mucin  (10)  and were 
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kindly  supplied by Dr.  Hans Faillard,  Ruhr-Universit~t  Bochum,  Germany.  Various con- 
centrations  of these materials  (in 0.1 ml) were added  to other components of the phagocy- 
tosis system as described above. 
Preparations  of 7S and 19S immunoglobulins were isolated from serum by gel filtration at 
4°C with Sephadex G-200 in phosphate-saline  buffer, pH 7.6. 2 ml fractions were collected 
and the protein  concentration  determined  spectrophotometrically  at 280 m~. Each fraction 
was tested for opsonic activity and the immunoglobulin identified by gel diffusion using goat 
antiserum  to human 7S and 19S immunoglobulins (Hyland Laboratories  Inc., Los Angeles 
Calif.). 
Normal and immune sera were incubated with zymosan (Fleischmann Laboratories,  New 
York) for 2 hr at 37°C (11), after which time the zymosan was sedimented and the serum 
removed and immediately tested. 
RESULTS 
Opsonins After Meningococcal Polysaccharide Immunization.--The interaction 
between  meningococcal strain  A-l,  the prototype group A  strain,  and human 
leukocytes in the presence of pre- and postimmunization  sera  is  demonstrated 
in  Fig.  1.  Strain  A-1  multiplied  in  the  presence  of preimmunization  serum, 
whereas  phagocytosis readily  occurred when  this  strain  and  leukocytes  were 
incubated  with  group  A  polysaccharide  antiserum.  The  extracellular  count 
closely paralleled  the  total  count  (extracellular  and  intracellular  organisms), 
indicating that after ingestion by leukocytes meningococci were rapidly killed. 
The immune serum control without  leukocytes showed no bactericidal  effect. 
In addition, if tubes were left static and not tumbled so as to preclude adequate 
contact between leukocyte and bacterial populations, minimal killing occurred, 
thus demonstrating  the  absence of extracellular  killing  in the intact  system. 
Similar  findings  were  observed  when  strain  C-11,  the  prototype  group  C 
strain,  and  leukocytes  were  incubated  in  the  presence  of  group  C  polysac- 
charide antisera, i.e., strain C-11 multiplied in the presence of preimmunization 
serum and phagocytosis occurred with postimmunization serum. After ingestion 
by leukocytes, these organisms were also rapidly killed.  Phagocytosis of strain 
C-11 in the presence of pre- and postimmunization sera is shown morphologically 
in Figs. 7a and 7b. Details of this  technique have been described previously (6). 
In Fig. 7a, strain C-11 was incubated for 1 hr with a monolayer of leukocytes in 
the presence of preimmunizafion serum. Most organisms, stained with Wright- 
Giemsa remained  extracellular.  After incubation of this strain in the presence 
of leukocytes and group C polysaccharide antiserum,  organisms were observed 
either on or in phagocytic cells  (Fig. 7b). In addition,  many intracellular  bac- 
teria lost their staining properties  and degranulation of granulocytes occurred. 
Similar  morphologic findings  were  seen  when  strain  A-1  was  incubated  with 
human  granulocytes  and  group  A  polysaccharide  antiserum. 
Sera from 10 immunized volunteers were tested  and in all instances opsonic 
activity was demonstrated.  Examination of serial serum samples revealed that 
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least  14  months.  Titers  of  opsonic  activity  ranged  from  1:20  to  1:320;  the 
highest titers were noted in 2-4 wk antisera. 
Serologic Specificity of Serum Opsonins.--To  determine the serologic specific- 
ity of opsonins in group A and group C polysaccharide antisera, five additional 
meningococcal  strains  of  each  serologic  group  isolated  from both  cases  and 
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FIo.  1.  The interaction between meningococcal strain A-1 and leukocytes in the presence 
of  pre-  and  postimmunization sera. 
carriers as well as from different geographical areas were examined. Phagocyto- 
sis of only group A and group C strains was observed in the presence of homolo- 
gous antiserum. 
Antisera  were  also  absorbed  with  log-phase  organisms  and  meningococcal 
polysaccharides; results after absorption of group A polysaccharide antiserum 
are shown in Fig. 2. Opsonic activity was lost after absorption with strain A-I, 
whereas activity remained the same after absorption with either strain B-11 or 
C-11. Similar findings were observed after absorption with five other strains of Io7 
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each serologic group. Studies on absorption of the same antiserum with meningo- 
coccal polysaccharides revealed that absorption with group A  polysaccharide 
removed opsonic activity, whereas no effect was observed after absorption with 
group C polysaccharide, Immune serum controls showed no bactericidal effect. 
The findings after absorption of group C polysaccharide antiserum with log- 
phase organisms  and meningococcal polysaccharides are recorded in Table I. 
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FIG.  2.  The interaction between meningococcal strain A-1 and leukocytes in the presence 
of group A polysaccharide antiserum absorbed  with log-phase organisms and meningococcal 
polysaccharides. 
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Opsonic activity was lost after absorption with either strain C-11  or group C 
polysaccharide,  whereas  no  loss  was  observed  after  absorption  with  either 
strains A-1 and B-11 or with group A polysaccharide. Similar results were also 
obtained after absorption with other group A, B, and C meningococcal strains. 
Opsonins After Group A  and Group C Meningococcal Infections.--Group  C 
meningococcal opsonins were detected in the sera of two nasopharyngeal car- 
riers and three patients recovered from meningitis (examples shown in Fig. 3) 
but  not  in  preinfection sera.  Comparison  of  total  with  extracellular  counts 
indicated  that  rapid  intracellular killing of organisms  occurred. Morphologic 504  MENINGOCOCCAL  POLYSACCHARIDES  AND  SERUM  OPSONINS 
TABLE  I 
Phago~tos~ ~  ~ram  ~11  ~  the Pres~ce ~  Group  C  Po~saccharide Antiserum  Absorb~ 
w~hM~cocciandM~goco~d  Po~sacehar~ 
Serum  Serum absorbed with:  Bacteria per m] (strain C-11) 
0 rain  60 rain  120 m{~ 
Preimmunizafion  --  1.4  X  107  4.1  X  107  8.0  X  107 
Postimmunization  --  1.3  X  10  7  3.0  X  10 3  <3.0  X  10  3 
"  Strain A-1  1.0  )  10  7  7.0  X  10 3  <3.0  X  10 3 
"  Strain B-11  1.0  X  10 7  7.0  X  10  3  <3.0  X  10  ~ 
"  Strain C-11  1.2  X  10  7  3.3  X  10 7  7.0  X  10 7 
"  A polysaccharide  1.0  X  10 7  4.0  X  10 3  3.0  X  10  3 
"  C  polysaccharide  1.2  X  10  7  2.8  X  10 7  7.2  X  10 7 
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FIG.  3.  Phagocytosis of strain C-11 in the presence of sera from a  nasopharyngeal carrier 
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findings were similar to those described for phagocytosis of strain C-11  in the 
presence of group C  polysaccharide antisera.  Opsonic activity was  lost from 
group C infection sera after absorption with group C meningococci. Absorption 
with group C  but not group A polysaccharide also removed opsonic activity 
from these sera (Fig. 4). Group A opsonic activity was also lost from the serum 
of naturally infected individuals after absorption with both the group-specific 
organism  and  the  group-specific polysaccharide. 
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Fl& 4. The interaction between strain C-It and leukocytes in the presence of group C 
infection serum absorbed with meningococcal  polysaccharides. 
Neutralization of Opsonic Activity in Meningococcal Polysaccharide  A ntisera.-- 
Gotschlich  et  al.  reported  that  group  A  meningococcal polysaccharide is  a 
polymer of N-acetyl, O-acetyl mannosamine PO4 (7). It was therefore of interest 
to study the inhibitory effect of closely related haptens on the phagocytosis of 
strain A-1 in the presence of group A polysaccharide antisera. Results of opsonin 
neutralization with increasing concentrations of low molecular weight group A 
polysaccharide and N-acetyl mannosamine are demonstrated in Fig.  5.  Stud- 506  MENINGOCOCCAL  POLYSACCHARIDES AND  SERUM OPSONINS 
ies  of  this  antiserum  were  performed  at  a  1:20  dilution  because  of the 
relatively  high  titer  of  opsonic  activity  (1:80).  Phagocytosis  of  strain  A-1 
was prevented at polysaccharide concentrations  of 50 and  100/zg/ml,  and at 
N-acetyl mannosamine  concentrations  of  100  and  1000  #g/ml.  Similar  con- 
centrations  of N-acetyl  mannosamine  had  no  effect  on  the  phagocytosis  of 
staphylococcus albus in the presence of 10% fresh normal serum or of meningo- 
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FIG. 5.  The interaction between strain A-1  and ]eukocytes in  the presence of group  A 
polysaccharide antiserum  (1:20  dilution)  and  increasing concentrations of group  A  poly- 
saccharide and N-acetyl mannosamlne. 
coccal strain C-11  in the presence of group C  polysaccharide antiserum. Neu- 
tralization studies with other haptens are sunlmarized in Table n.  Concentra- 
tions  up  to  1000  /~g/ml  mannose,  mannosamine,  N-acetyl  glucosamine,  N- 
acetyl galactosamine, and N-acetyl neuraminic acid did not reverse the opsonic 
action of the 1 : 20 antiserum. At these concentrations, there was no bactericidal 
effect in immune serum controls without  leukocytes.  Group A polysaccharide 
antisera from four other volunteers were examined  and  similar findings were 
observed in three. However, in one group A polysaccharide antiserum N-acetyl 
mannosamine at  concentrations  up to  10 mg/ml  had  no neutralizing  effect. RICHARD  B.  ROBERTS  507 
It has  also been reported  that  group C  meningococca! polysaccharide is  a 
polymer of N-acetyl, O-acetyl neuraminic acid (7, 12). Concentrations as low as 
0.1/zg/ml  of this polysaccharide inhibited  the phagocytosis of strain  C-11  in 
the  presence  of  homologous  antisera.  However,  neutralization  of  opsonic 
activity in  these  antisera  was not  observed with  1.0-100  /~g/ml of N-acetyl 
neuraminic acid,  N-acetyl-4-O-acetyl neuraminic  acid,  or  N-acetyl-7-O, 8-0- 
diacetyl  neuraminic  acid.  Concentrations  up  to  1000  /zg/ml  mannose,  man- 
nosamine, N-acetyl mannosamine, N-acetyl glucosamine,  and N-acetyl galac- 
tosamine  also  had  no  effect. 
Effect of Heat-Labile Factors  on Opsonic Activity.--Previous studies  demon- 
strated  that  the  activity  of  meningococcal  opsonins  in  immune  rabbit  sera 
depended on heat-labile components present in both normal and immune sera 
(6); opsonic titers in these rabbit antisera were consistently low (1:10-1:20). 
TABLE II 
Inhibition of Phagocytosis of Strain A-1 in the Presence of Group A Polysacchar~te 
Antiserum (1:20) 
Inhibitor  Bacteria per ml (strain A-l) 
I000 I~g/ml  0 mln  60 rain  lZO m~n 
Mannose  1.5  X  107  7.0  X  l0 s  3.0  X  10  a 
Mannosamine  1.3  X  107  7.0  X  l0 s  3.0  X  10  a 
N-acetylmannosamine  1.6  X  107  3.1  X  107  6.0  X  107 
N-acetyl glucosamine  1.0  X  107  5.0  X  103  <3.0  X  l0 S 
N-acetyl galactosamine  12  X  107  6.0  X  103  3.0  X  103 
N-acetyl neuraminic acid  1.2  X  107  5.0  X  l0 S  <3.0  X  10  s 
None  1.4  X  l0 T  7.0  X  l0 s  3.0  X  l0 s 
In the present studies, the activity of low-titer opsonins in human antisera after 
polysaccharide  immunization  also  depended  on  heat-labile  factors:  in  the 
presence  of  10%  heat-inactivated  immune  serum  and  10%  heat-inactivated 
normal serum, multiplication of log-phase organisms occurred. 
Similar  experiments  were  performed  'using  polysaccharide  antisera  with 
relatively high titers of opsonins (1:160--1:320).  Phagocytosis was observed in 
the presence of heat-inactivated antisera although the titers of opsonic activity 
were reduced to 1 : 10. Similar findings were observed after treatment of normal 
or immune sera with 1-5 mg zymosan. Mter ingestion in the presence of heat- 
inactivated or zymosan-treated antisera, rapid intracellular killing of meningo- 
cocci  was  observed. 
Opsonic  Capacity  of  7S  and  19S  Serum  Fractions.--7S  and  19S  immuno- 
globulins were prepared by gel filtration from 3 ml of antiserum collected from 
volunteers  12  months  after polysaccharide  immunization.  All  fractions  were 
tested  for  opsonic  activity  in  the  presence  of  10%  fresh  normal  serum.  As 508  M:ENINGOCOCCAL  :POLYSACCHARIDES  AND  SERUM  OPSONINS 
demonstrated  in  Fig.  6,  opsonic  activity  was  detected  in  both  19S  and  7S 
fractions. Though in all determinations the opsonic titers were relatively low, 
most activity was associated with the 7S fraction. As observed in studies of heat- 
inactivated low-titer antisera,  phagocytosis did not  occur in  the presence of 
either the  19S or 7S fraction and  10% heat-inactivated normal serum. 
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Fie. 6. The separation of group A polysaccharide  antiserum by Sephadex G-200 filtration. 
Opsonic activity is represented by the shaded bars. 
DISCUSSION 
The interaction between meningococci and human leukocytes in the presence 
of human sera has been determined in past studies by stained smears (13-15). 
Although conflicting results have been reported, phagocytosis of meningococci 
in the presence of sera from naturally infected individuals has been described 
(14). Because of severe clumping and retraction of leukocytes, however, quanti- 
tation by this  technique is  unreliable.  The methods  employed in  this  study 
allow quantitative evaluation of the interaction between meningococci, leuko- 
cytes, and serum factors. Consideration of the  concentration of reactants,  as 
well as other important variables in such a phagocytosis system has been re- 
viewed previously  (6,  16). 
The findings  demonstrate  that  immunization  with  group A  and  group  C 
meningococcal polysaccharides produces serum opsonins in man. Furthermore, 
these opsonins are present in both 19S and 7S immunoglobulins and persist in 
high titers for at least 14 months. The demonstration of opsonic activity after 
immunization  is  consistent  with  studies  by  Gotschlich,  Goldschneider,  and 
Artenstein who detected hemagglutinating and serum bactericidal activity in 
polysaccharide antisera (8). Concentrations of 104 organisms/ml and 25 % fresh 
serum were employed in  the study of serum  bactericidins by these  authors. 
Since  the  presence  of  bactericidal  activity  makes  it  impossible  to  observe 
opsonic effects by the method which uses intracellnlar killing of bacteria as an 
index of phagocytosis, different concentrations of reactants were employed in 
the present studies.  At concentrations of 1-2  X  107 organisms/ml  and  10% 
fresh  sera,  opsonic  activity could  be detected,  whereas  bactericidal  activity 
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Absorption  of polysaccharide antisera with log-phase organisms and poly- 
saccharides, as well as phagocytosis of group A and group C meningococci only 
in the presence of homologous antisera, suggest that meningococcal opsonins 
are group-specific.  Group-specificity of serum opsonins has also been observed 
in animals immunized with groups A and C log-phase meningococci.  ~ It will be 
of interest to study serum opsonins after group B meningococcal polysaccharide 
immunization, since type-specific opsonins in sera of rabbits immunized with 
log-phase group B strains have been reported (6). 
Meningococcal opsonins were  also detected in  the sera  of nasopharyngeal 
carriers and of patients recovered from meningitis. Because of the small sample 
of patients studied, the role of these antibodies in natural immunity to meningo- 
coccal infections requires further study. Results after absorption of these sera 
with log-phase bacteria and meningococcal polysaccharides suggest that these 
polysaccharides are the major  antiphagocytic determinants for groups A  and 
C  meningococci. Minor determinants should also be kept in mind since such 
factors have been described for other bacteria-phagocyte interactions (17,  18). 
Previous studies demonstrated that group A meningococcal polysaccharide 
is a polymer of N-acetyl, O-acetyl mannosamine PO~, and that the high molecu- 
lar weight form of this polysaccharide (greater than 100,000)  inhibits hemag- 
glutinating activity at concentrations of 0.5-2.5/zg/ml (7). The relatively high 
concentrations of group A  polysaccharide that were  necessary to  neutralize 
opsonic activity may be related, as suggested by these authors  to differences 
in the molecular weights of polysaccharide preparations. Phagocytosis of group 
A meningococci in the presence of group A polysaccharide antisera was also 
inhibited by N-acetyl mannosamine. This  inhibition was specific,  as similar 
concentrations of N-acetyl mannosamine had no effect on the phagocytosis of 
staphylococcus  albus  or  group  C  meningococci.  In  addition,  other  closely 
related haptens did not neutralize group A  opsonic activity. The lack of  an 
inhibitory effect of N-acetyl mannosamine in the sera from one volunteer sug- 
gests  that  certain group  A  polysaccharide antisera recognize  a  determinant 
other than N-acetyl mannosamine. In these cases it seems likely that the O- 
acetylation of N-acetyl mannosamine may be necessary for neutralization of 
opsonic activity. 
Phagocytosis of group C meningococci in the presence of group C  polysac- 
charide antisera was inhibited by group C polysaccharide (polymer of N-acetyl, 
O-acetyl neuraminic acid) but not by N-acetyl neuraminic acid, N-acetyl-4-O- 
acetyl neuraminic  acid,  or  N-acetyl-7-O,  8-O-diacetyl  neuraminic  acid.  In 
addition, no effect was observed when colominic acid (N-acetyl neuraminic acid 
extracted from Escherichia  coli) was added to the phagocytosis system (19). 3 
These  results  are  consistent  with  previous  reports  demonstrating  the  lack 
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of biologic activity of free acyl-neuraminic acids. Studies on the phagocytosis of 
group C meningococci after treatment of these organisms and group C poly- 
saccharide with bacterial neuraminidase are now in progress. 
Differential centrifugation to separate leukocyte from bacterial populations 
and direct colony plating, as well as morphologic studies, indicate that after 
ingestion  by  human  granulocytes,  meningococci  are  rapidly  killed.  Similar 
findings have been observed in the study of phagocytosis of meningococci by 
rabbit polymorphonuclear leukocytes (6). The intracellular killing of meningo- 
cocci  does  not  depend  on  the  presence  of  either  heat-labile  components  or 
specific  opsonins  since  similar killing  rates  have  been  observed  with  heat- 
inactivated antisera  and  after ingestion of stationary-phase meningococci in 
the presence  of fresh normal serum.  4 These findings are  similar to  those  of 
Smith, Barnett, May, and Sanford who demonstrated that the effect of opson- 
ins on the phagocytosis of Proteus  mirabilis  by rabbit granulocytes was due to 
enhanced uptake rather than increased intracellular killing of bacteria  (20). 
Observations  on  complement  requirements  for  erythrophagocytosis  by 
polymorphonuclear and mononuclear leukocytes have demonstrated that for 
efficient phagocytosis of red cells,  7S antibody and the first four components 
of  complement  are  required  (21, 22).  Phagocytosis  of  pneumococci  in  the 
presence  of type-specific opsonins  and  heat-labile  factors has  recently been 
reported  by  Johnston,  Klemperer,  Alper,  and  Rosen  (23).  These  authors 
demonstrated that optimal phagocytosis of pneumococci requires 7S antibody, 
the first four components of complement, a heat-labile, dialyzable cofactor and 
a  heat-labile,  5-6S,  beta pseudoglobulin.  In  the presence  of these heat-labile 
serum factors the rate of phagocytosis was similar to that observed with fresh 
immune serum. The present studies demonstrate that phagocytosis of meningo- 
cocci occurs in the absence of heat-labile serum factors when titers of opsonic 
activity in fresh immune sera are relatively high. However, optimal ingestion 
of meningococci is  observed in the presence of both antibody and heat-labile 
factors.  Further  studies  to  characterize  the  heat-labile  factors  required  for 
optimal phagocytosis of meningococci are indicated. 
The findings described herein support and extend recent studies suggesting 
that immunization with groups A  and C meningococcal polysaccharides may 
well provide group-specific protection against meningococcal infections (8, 24). 
SITI~MARY 
The interaction in vitro between human granulocytes and meningococci in 
the presence of sera from volunteers immunized by Gotschlich et al. with puri- 
fied group A and group C meningococcal polysaccharides was studied. Phago- 
cytosis of meningococci did not occur in the presence of preimmunization sera. 
In all volunteers tested, group-specific opsonins were detected in groups A and 
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C  polysaccharide  antisera.  Opsonic  activity appeared  within  1  wk  after im- 
munization  and  persisted  for  at  least  14  months.  Titers  of  opsonic  activity 
ranged from 1:20 to 1:320; highest titers were noted in 2-4 wk antisera. Men- 
ingococcal  opsonins  were  detected  in  both  19S  and  7S  immunoglobulins. 
Opsonic activity in low-titer antisera depended  on heat-labile factors present 
in  both  normal  and  immune sera,  whereas  phagocytosis was observed in the 
presence  of  heat-inactivated  high-titer  antisera.  Phagocytosis  of  group  A 
meningococci in the presence of certain  group A  polysaccharide  antisera was 
inhibited  by  N-acetyl  mannosamine,  but  not  by  mannose,  mannosamine, 
N-acetyl glucosamine,  N-acetyl galactosamine,  or N-acetyl neuraminic  acid. 
Absorption studies with sera from patients with natural meningococcal infec- 
tions revealed that these polysaccharides are the major antiphagocytic deter- 
minants for group A  and group C meningococci. These studies  are consistent 
with previous reports suggesting that immunization with group A and group C 
polysaccharides may well provide group-specific protection  against  meningo- 
coccal infections. 
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terial, to Dr. J. Zabriskie, Dr. H. Faillard, and Dr. J. G. Hirsch for helpful discussions, and 
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FIG. 7.  (a): The interaction between strain C-11  and granulocytes incubated for 
1 hr in the presence of preimmunization serum. Most organisms stained with Wright- 
Giemsa remain extracellular. The cytoplasmic granules of leukocytes appear intact. 
X  1760. (b): The interaction between strain C-11  and granulocytes incubated for 1 
hr in the presence of group C polysaccharide antiserum. Organisms are observed either 
on  or in phagocytic cells and  degranulation has  occurred in  cells containing many 
bacteria. X  1760. 